MET and neoplasm: An explanation for this discrepancy can be found in (1) differences in expression between tumors of different locations and variations that occur in c-Met expression during tumor progression and (2) variation in the standards used for interpretation of the immunohistochemical results due to the lack of a universally accepted scoring principle.